Physician profile
William Sherman
NPI 1598812703
$3,165.35
in general payments reported to CMS, 2019-2025
14 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $127 · 2021: $13.36 · 2022: $1,208 · 2023: $970 · 2024: $561 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,178 · Consulting Fee: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,177.87 |
| Consulting Fee | $465.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $896.39 | 2020-2022 | |
| Becton, Dickinson and Company | $465.00 | 2024 | |
| Avita Medical Americas, LLC | $254.32 | 2022 | |
| Vericel Corporation | $240.44 | 2023 | Nexobrid, Epicel (Cultured Epidermal Autografts) |
| Polynovo North America LLC | $236.45 | 2022-2023 | |
| Teleflex LLC | $225.74 | 2021-2024 | Quikclot |
| Integra Lifesciences Corporation | $189.00 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medtronic, INC. | $165.35 | 2023 | Signia |
| Prytime Medical Devices, INC. | $111.94 | 2025 | Er-Reboa Plus |
| Atricure, INC. | $107.83 | 2023 | |
| Kci USA, INC. | $100.00 | 2019 | |
| Acell, INC. | $74.41 | 2019 | |
| Clr Medical, INC. | $55.00 | 2024 | Irrigator |
| Smith+Nephew, INC. | $43.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Sherman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.